Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00591799 · ClinicalTrials.gov registry record · Phase 2
Jarvik 2000 Heart as a Bridge to Cardiac Transplantation - Pivotal Trial
A Phase 2 study, sponsored by Jarvik Heart.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00591799: Completed Phase 2 study, sponsored by Jarvik Heart.
NCT00591799 is a Phase 2 study that has completed, run by Jarvik Heart. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00591799, a Phase 2 study, has completed, sponsored by Jarvik Heart.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the safety and effectiveness of the Jarvik 2000 Heart as a bridge to heart transplantation in end-stage heart failure patients who are approved heart transplant candidates.
Interventions
- DEVICE The Jarvik 2000 Ventricular Assist System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-04 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00591799
The ClinicalTrials.gov registry entry for NCT00591799 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jarvik Heart, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which The Jarvik 2000 Ventricular Assist System is the first listed.
NCT00591799 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00591799 about?
NCT00591799 is a clinical study titled "Jarvik 2000 Heart as a Bridge to Cardiac Transplantation - Pivotal Trial". The purpose of the study is to determine the safety and effectiveness of the Jarvik 2000 Heart as a bridge to heart transplantation in end-stage heart failure patients who are approved heart transplant candidates.
What is the current status of trial NCT00591799?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2005-04. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00591799?
The interventions under investigation include: The Jarvik 2000 Ventricular Assist System (DEVICE).
Who is sponsoring clinical trial NCT00591799?
This trial is sponsored by Jarvik Heart, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.